Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09914-cover-thermo.jpg

April 19, 2021 Cover

Volume 99, Issue 14

A few ambitious companies are pioneering a new industry serving the emerging sector

Cover image:New laboratory space at Aldevron. The manufacturer of starting materials for cell and gene therapies and enzymes plans to more than triple capacity this year.

Credit: Aldevron

Full Article
Volume 99 | Issue 14

All Issues

Quote of the Week

“The fundamental challenge in cell therapy is that you’re building the plane as you fly it.”

John Khoury, executive vice president, Project Farma

Cell and gene therapy: The next frontier in pharmaceutical services

A few ambitious companies are pioneering a new industry serving the emerging sector

  • Chemistry textbooks still lack gender and racial representation

    Bias and lack of diversity in textbook images can harm students

  • How to get the most out of informational interviews

    Use these casual conversations to guide your career exploration and grow your network

  • Periodic Graphics: Faking flavors with chemistry

    Chemical educator and Compound Interest blogger Andy Brunning provides a taste of how chemists identify and make artificial flavors.

ADVERTISEMENT
image name
Vaccines

Pause remains on J&J vaccine

CDC’s vaccine advisory committee will watch and wait before deciding on the J&J vaccine

ADVERTISEMENT
ADVERTISEMENT